Contact Information
Company Information
Professional Summary
Mark Womack serves as Chief Executive Officer at BioCina and Member at BioCina. BioCina operates in the pharmaceuticals sector with approximately 160.0 employees. To date, BioCina has raised 3323675.0 in total funding, with the most recent round being Other.
Industry & Role Insights
-
•
MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
-
•
Our database includes 201,468 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
GoDaddy Hosting
Salesforce
Apache
YouTube
Google Font API
Mobile Friendly
Google Analytics
Google Tag Manager
WordPress.org
IoT
Remote
AI
Keywords
microbial
ecoli
proteins
cdmo
vaccines
biotechnology
manufacturing
plasmids
pdna
recominant proteins
fermentation
peptides
cmo
fda
mrna
pharmaceutical manufacturing
biologics
contract development manufacturing organization
microbial manufacturing
quality by design
process development
cgmp manufacturing
analytical development
technology transfer
clinical trials
commercial manufacturing
regulatory compliance
fda approved
cell & gene therapies
scale-up
deep knowledge
operational excellence
quality assurance
quality control
client-centric
on-time delivery
in-full delivery
strategic partnerships
custom solutions
research & development
life sciences
biopharmaceuticals
biomanufacturing
advanced equipment
process optimization
product development
clinical stage
commercialization
risk mitigation
manufacturing facilities
technical expertise
next-generation therapeutics
biological products
adjuvants
research partnerships
client programs
end-to-end solutions
biotech innovations
operation management
supply chain management
project management
mechanical or industrial engineering
pharmaceuticals
medical
health care
health
wellness & fitness
hospital & health care
logistics & supply chain
productivity
Related Executives
Outreach Guidance — pharmaceuticals Sector
Executives like Mark Womack in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at BioCina.
Mark Womack's Position in the MessageCEO Database
- •Mark Womack is 1 of 1 verified executive contact we track at BioCina.
- •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
- •21 verified contacts work at pharmaceuticals companies in the 160.0 employee range (same size as BioCina).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Frequently Asked Questions
How do I reach Mark Womack directly?
Mark Womack's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at BioCina and Member at BioCina. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Mark Womack work for?
Mark Womack is Chief Executive Officer at BioCina and Member at BioCina, a company in the pharmaceuticals sector with 160.0 employees.
Can I pitch or sell to Mark Womack?
As Chief Executive Officer at BioCina and Member at BioCina, Mark Womack is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Mark Womack directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Mark Womack in?
Mark Womack works in the pharmaceuticals industry as Chief Executive Officer at BioCina and Member at BioCina. MessageCEO provides verified contact information for executives across all major industries.
Is Mark Womack's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Womack's profile is kept up-to-date with the latest available information.
Last updated: July 26, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans